AbCellera Biologics (ABCL) Share-based Compensation (2020 - 2026)
AbCellera Biologics' Share-based Compensation came in at $12.29 million for Q2 2026, down 13.5% from $14.21 million a year earlier but up 2.3% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, AbCellera Biologics reported Share-based Compensation of $51.1 million, down 16.8% year-over-year; for FY2025, it was $55.79 million, down 17.4% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of 46.0% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $67.58 million in FY2024 (+5.3%), $64.18 million in FY2023 (+29.7%), $49.48 million in FY2022 (+61.5%) and $30.65 million in FY2021 (+265.0%).
- The five-year range for quarterly Share-based Compensation is $7.71 million (Q3 2021) to $17.78 million (Q2 2024).
- Year-over-year, Share-based Compensation has declined for seven consecutive quarters, with an average decline of 12.6% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2021 (growth of 299.0%), and the weakest in Q2 2025 (a decline of 20.1%).
- Business Quant data shows ABCL's Share-based Compensation at $12.01 million (Q1 2026), $12.9 million (Q4 2025) and $13.9 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | - |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 170.20 Mn |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - | 12.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.29 Mn |
| Mar 31, 2026 | 12.01 Mn |
| Dec 31, 2025 | 12.90 Mn |
| Sep 30, 2025 | 13.90 Mn |
| Jun 30, 2025 | 14.21 Mn |
| Mar 31, 2025 | 14.79 Mn |
| Dec 31, 2024 | 15.23 Mn |
| Sep 30, 2024 | 17.16 Mn |
| Jun 30, 2024 | 17.78 Mn |
| Mar 31, 2024 | 17.41 Mn |
| Dec 31, 2023 | 16.45 Mn |
| Sep 30, 2023 | 15.86 Mn |
| Jun 30, 2023 | 16.40 Mn |
| Mar 31, 2023 | 15.47 Mn |
| Dec 31, 2022 | 13.32 Mn |
| Sep 30, 2022 | 11.75 Mn |
| Jun 30, 2022 | 12.11 Mn |
| Mar 31, 2022 | 12.29 Mn |
| Dec 31, 2021 | 9.04 Mn |
| Sep 30, 2021 | 7.71 Mn |
API Access
AbCellera Biologics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();